Clarendon Fund Managers Ltd. β 2022 Investments
3 investments dated 2022 Β· listed companies and verified rows first Β· show all
Amply is a store operations platform that moves daily retail workflows from paper and spreadsheets into a single app, offering task checklists, scheduled SOPs, digital store visit audits, a communication feed, and AI-powered image verification for visual merchandising.
AI & Machine LearningRetail TechSaaS
Anshul Goyal(Founder)in
Co-investorsIIMA VenturesBritish Business BankQUBISTechstarsTwin Path Venturesventure / science
Aramune develops pharmaceutical and nutraceutical products targeting diseases including diabetes, obesity, cardiovascular disease, and neurodegenerative conditions.
AgTechBiotechFoodTechHealthtechMedical DevicesBelfast, GB
Brian(Professor of Molecular Nutrition)Chris Nicklin
BoardStuart
Co-investorsQUBIS
VascVersa develops a platform for vascular stem cell therapy and cell therapy manufacturing, serving the advanced therapies and clinical development sectors in vascular biology.
BiotechDeep TechHealthtechBelfast, GB
Professor Alan Stitt(Co-founder)Dr Christina O'Neill(Co-founder, CEO)Prof Reinhold Medina(Co-founder)
Co-investorsQUBIS
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.